BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37866544)

  • 1. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway.
    Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G
    Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis.
    Wang Q; Li G; Ma X; Liu L; Liu J; Yin Y; Li H; Chen Y; Zhang X; Zhang L; Sun L; Ai J; Xu S
    Cell Death Dis; 2023 Feb; 14(2):76. PubMed ID: 36725842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00926 is involved in hypoxia-induced vascular endothelial cell dysfunction
    Jiang Y; Xu CH; Zhao Y; Ji YH; Wang XT; Liu Y
    Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36647631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
    Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
    Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Xu F; Wang H; Tian J; Xu H
    Neurochem Res; 2021 Aug; 46(8):2192-2203. PubMed ID: 34050453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
    Wang K; Jin W; Song Y; Fei X
    Mol Cancer; 2017 Oct; 16(1):166. PubMed ID: 29070041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
    Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
    Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q; Zhao Y; Sun Y; Yan X; Wang P
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.
    Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N
    Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
    Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
    Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
    Tian P; Wei JX; Li J; Ren JK; Yang JJ
    Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.
    Mineo M; Lyons SM; Zdioruk M; von Spreckelsen N; Ferrer-Luna R; Ito H; Alayo QA; Kharel P; Giantini Larsen A; Fan WY; Auduong S; Grauwet K; Passaro C; Khalsa JK; Shah K; Reardon DA; Ligon KL; Beroukhim R; Nakashima H; Ivanov P; Anderson PJ; Lawler SE; Chiocca EA
    Mol Cell; 2020 Jun; 78(6):1207-1223.e8. PubMed ID: 32504554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
    Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
    Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA LINC01133 Promotes the Malignant Behaviors of Renal Cell Carcinoma by Regulating the miR-30b-5p/Rab3D Axis.
    Zhai X; Wu Y; Wang Z; Zhao D; Li H; Chong T; Zhao J
    Cell Transplant; 2020; 29():963689720964413. PubMed ID: 33054325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
    Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
    Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.